Enhancing bioavailability and hepatoprotective activity of andrographolide fromAndrographis paniculata, a well-known medicinal food, through its herbosome
- 4 November 2009
- journal article
- research article
- Published by Wiley in Journal of the Science of Food and Agriculture
- Vol. 90 (1), 43-51
- https://doi.org/10.1002/jsfa.3777
Abstract
BACKGROUND: Andrographis paniculata is a health food used extensively in Southeast Asia, India and China and contains the pharmacologically important phytochemical andrographolide. Although andrographolide has antihepatotoxic activity, its bioavailability from A. paniculata is restricted by its rapid clearance and high plasma protein binding. The aim of this study was to formulate a herbosome of andrographolide with a naturally occurring phospholipid in order to enhance the bioavailability and hepatoprotective activity of andrographolide in rats. RESULTS: Andrographolide herbosome equivalent to 25 and 50 mg kg−1 andrographolide significantly protected the liver of rats, restoring hepatic enzyme activities with respect to carbon tetrachloride-treated animals (P < 0.05 and P < 0.01 respectively). The rat plasma concentration of andrographolide obtained from the complex equivalent to 25 mg kg−1 andrographolide (Cmax = 9.64 µg mL−1) was higher than that obtained from 25 mg kg−1 andrographolide (Cmax = 6.79 µg mL−1), and the complex maintained its effective plasma concentration for a longer period of time. CONCLUSION: The results proved that the andrographolide complex produced by this method has better bioavailability and hence improved hepatoprotective activity compared with andrographolide at the same dose. Andrographolide complexation is therefore helpful in solving the problem of rapid clearance and low elimination half-life associated with andrographolide from A. paniculata. Copyright © 2009 Society of Chemical IndustryKeywords
This publication has 33 references indexed in Scilit:
- Exploring the Effect of Hesperetin–HSPC Complex—A Novel Drug Delivery System on the In Vitro Release, Therapeutic Efficacy and PharmacokineticsAAPS PharmSciTech, 2009
- Pharmacokinetics of raloxifene in male Wistar–Hannover rats: Influence of complexation with hydroxybutenyl-beta-cyclodextrinInternational Journal of Pharmaceutics, 2007
- Andrographolide Reduces Inflammation-Mediated Dopaminergic Neurodegeneration in Mesencephalic Neuron-Glia Cultures by Inhibiting Microglial ActivationJournal of Pharmacology and Experimental Therapeutics, 2004
- Antihyperglycemic Effect of Andrographolide in Streptozotocin-Induced Diabetic RatsPlanta Medica, 2003
- Andrographolide, a potential cancer therapeutic agent isolated from Andrographis paniculataJournal of Experimental Therapeutics and Oncology, 2003
- Andrographolide prevents oxygen radical production by human neutrophils: possible mechanism(s) involved in its anti‐inflammatory effectBritish Journal of Pharmacology, 2002
- Aspects of the male reproductive toxicity/male antifertility property of andrographolide in albino rats: effect on the testis and the cauda epididymidal spermatozoaPhytotherapy Research, 2000
- Targeting of Liposomal Andrographolide toL.donovani-Infected Macrophages in VivoDrug Delivery, 2000
- Use of visual analogue scale measurements (VAS) to asses the effectiveness of standardized Andrographis paniculata extract SHA-10 in reducing the symptoms of common cold. A randomized double blind-placebo studyPhytomedicine, 1999
- Prevention of common colds with Andrographis paniculata dried extract. A Pilot double blind trialPhytomedicine, 1997